Soc. Generale Knock-Out ABT/ DE000SB0ZKG9 /
03/05/2024 21:43:07 | Chg.+0.02 | Bid22:00:37 | Ask22:00:37 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
1.46EUR | +1.39% | - Bid Size: - |
- Ask Size: - |
Abbott Laboratories | 90.2173 USD | 31/12/2078 | Call |
GlobeNewswire
25/03
Tricares Announces the Appointment of Ahmed Elmouelhi as President & Chief Executive Officer
GlobeNewswire
15/03
Attention Reckitt Benckiser Group investors: Portnoy Law Firm Announces Investigation into Reckitt B...
GlobeNewswire
14/11/2023
NeuroOne® Appoints Medtech Executive Christopher R. Volker as Chief Operating Officer and Reports In...
GlobeNewswire
19/10/2023
Catalyst Pharmaceuticals Appoints Richard J. Daly as Chief Executive Officer
GlobeNewswire
10/10/2023
Blue Water Biotech Appoints Dr. Neil J. Campbell as President and CEO and Bruce Harmon as CFO
GlobeNewswire
02/10/2023
Apnimed Adds Independent Director Paul Fonteyne, MS, MBA to Board of Directors
GlobeNewswire
06/09/2023
Endexx Corporation Appoints Ahmed Itani to Director of Marketing of HYLA in The Middle East Region